Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Agilon Health (AGL) Net Income towards Common Stockholders: 2019-2024

Historic Net Income towards Common Stockholders for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to -$9.8 million.

  • Agilon Health's Net Income towards Common Stockholders rose 25084.58% to $14.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 11983.5%. This contributed to the annual value of -$9.8 million for FY2024, which is 8545.67% up from last year.
  • According to the latest figures from FY2024, Agilon Health's Net Income towards Common Stockholders is -$9.8 million, which was up 8545.67% from -$67.6 million recorded in FY2023.
  • In the past 5 years, Agilon Health's Net Income towards Common Stockholders registered a high of $3.2 million during FY2020, and its lowest value of -$67.6 million during FY2023.
  • Over the past 5 years, Agilon Health's median Net Income towards Common Stockholders value was -$14.6 million (recorded in 2022), while the average stood at -$22.3 million.
  • As far as peak fluctuations go, Agilon Health's Net Income towards Common Stockholders soared by 10171.1% in 2020, and later crashed by 82639.42% in 2021.
  • Annual analysis of 5 years shows Agilon Health's Net Income towards Common Stockholders stood at $3.2 million in 2020, then crashed by 826.39% to -$22.9 million in 2021, then surged by 36.51% to -$14.6 million in 2022, then tumbled by 364.13% to -$67.6 million in 2023, then surged by 85.46% to -$9.8 million in 2024.
  • Its Net Income towards Common Stockholders was -$9.8 million in FY2024, compared to -$67.6 million in FY2023 and -$14.6 million in FY2022.